Patents by Inventor Tania Aguado

Tania Aguado has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT AND PREVENTION OF GLIOBLASTOMA
    Publication number: 20220008362
    Abstract: The invention relates to the use of a selective ?2 adrenergic receptor antagonist for treating glioma. In particular, the invention relates to the use of an alkanolamine derivative or a pharmaceutically acceptable acid-addition salt thereof for treating a glioblastoma in a patient.
    Type: Application
    Filed: December 12, 2019
    Publication date: January 13, 2022
    Inventors: José María SÁNCHEZ-PUELLES GONZÁLEZ-CARVAJAL, Luisa María BOTELLA CUBELLS, Tania AGUADO SANCHEZ, Ángel CUESTA MARTÍNEZ, Virginia ALBIÑANA DÍAZ, Karina VILLAR GOMEZ-DE LAS HERAS
  • USE OF CB2 RECEPTOR AGONISTS FOR PROMOTING NEUROGENESIS
    Publication number: 20100004244
    Abstract: The present invention relates to ligands of the peripheral cannabinoid receptor CB2, especially (+)-?-pinene derivatives, and to pharmaceutical compositions thereof, which are useful for promoting, inducing and enhancing neurogenesis including neural cell regeneration. In particular, pharmaceutical compositions of the invention will be useful for preventing, alleviating or treating neurological injuries or damages to the CNS or the PNS associated with physical injury, ischemia, neurodegenerative disorders, certain medical procedures or medications, tumors, infections, metabolic or nutritional disorders, cognition or mood disorders, and various medical conditions associated with neural damage or destruction.
    Type: Application
    Filed: June 27, 2007
    Publication date: January 7, 2010
    Applicant: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
    Inventors: Ismael Galve-Roperh, Manuel Guzman, Raphael Mechoulam, Javier Palazuelos, Tania Aguado